General Report Contents

  • Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
  • Market Drivers & Limiters for each chapter segment
  • Competitive Analysis for each chapter segment
  • Section on recent mergers & acquisitions

The cartilage repair market can be segmented by product type, yielding four segments: osteochondral allografts, meniscal allografts, autologous chondrocyte implantation (ACI) products and osteochondral autografts. In 2016, the largest segment in the total cartilage repair market was the ACI segment, representing approximately 90% of the total market value. Future growth of the ACI market is highly dependent on the regulatory approval of products, which is overseen by the European Medicines Agency (EMA).
Due to stringent regulation and a lack of national reimbursement in most regions, several companies which were once active in the segment, such as TiGenix and Vericel, have either completely withdrawn from the market or shifted their focus to other regions in the world. Despite the uncertainty surrounding the EMA decision, the ACI market is expected to remain the largest segment in the total cartilage repair market over the forecast period.